Literature DB >> 17179834

Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease.

Francesca Cesari, Anna Maria Gori, Sandra Fedi, Rosanna Abbate, Gian Franco Gensini, Francesco Sofi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17179834     DOI： 10.1097/MBC.0b013e3280124f2c

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN： 0957-5235            Impact factor:   1.276


× No keyword cloud information.
  5 in total

1.  Protein Z-deficiency is associated with enhanced neointima formation and inflammatory response after vascular injury in mice.

Authors:  Antje Butschkau; Nana-Maria Wagner; Laura Bierhansl; Berit Genz; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome.

Authors:  Manal Fawzy Ghozlan; Amal Abd El-Hameed Mohamed; Deena Samir Eissa; Hassan Shehata Eldawy
Journal:  Indian J Hematol Blood Transfus       Date:  2018-08-13       Impact factor: 0.900

3.  Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response.

Authors:  T J Girard; N M Lasky; E A Tuley; G J Broze
Journal:  J Thromb Haemost       Date:  2013-02       Impact factor: 5.824

4.  Contribution of protein Z and protein Z-dependent protease inhibitor in generalized Shwartzman reaction.

Authors:  Antje Butschkau; Philipp Nagel; Eberhard Grambow; Dietmar Zechner; George J Broze; Brigitte Vollmar
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

5.  Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients.

Authors:  F Sofi; F Cesari; Y Tu; G Pratesi; R Pulli; C Pratesi; G F Gensini; R Abbate; S Fedi; G J Broze
Journal:  J Thromb Haemost       Date:  2009-02-18       Impact factor: 5.824
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.